InvestSMART

ResMed Inc. (ASX:RMD)

ALERT: Price-sensitive ASX Announcement for RMD
Current share price for RMD : $27.430 -15.02 (-35.38%)+
Announcement
Release
1 Aug 2025 8:20AM
Price at Release
$42.450
Full Release
download
Summary
ResMed Inc. reported strong financial results for the fourth quarter of FY2025, with significant increases in net income and revenue compared to the previous year. The GAAP net income for Q4 FY2025 was $379.7 million, while net revenue reached $1,347.9 million. The company also reported non-GAAP net income of $374.5 million and non-GAAP diluted earnings per share of $2.55. Total assets increased to $8,174.4 million, reflecting growth in both current and non-current liabilities. Cash flows from operating activities showed improvement, totaling $538.8 million for the quarter.
Key Points
  • ResMed reported GAAP net income of $379.7 million for Q4 FY2025, compared to $292.2 million in Q4 FY2024.
  • Net revenue for the quarter was $1,347.9 million, up from $1,223.2 million in the same quarter the previous year.
  • The company reported non-GAAP net income of $374.5 million, slightly lower than the GAAP figure due to adjustments.
  • Non-GAAP diluted earnings per share for Q4 FY2025 was $2.55 compared to $2.08 for Q4 FY2024.
  • ResMed's total assets as of June 30, 2025, were $8,174.4 million, up from $6,872.4 million on June 30, 2024.
  • The balance sheet showed an increase in both current and non-current liabilities compared to the previous year.
  • The company's cash flow from operating activities was $538.8 million for Q4 FY2025, up from $440.1 million in Q4 FY2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.